市場調査レポート
商品コード
1057101

循環腫瘍細胞(CTC)診断:技術と世界市場

Circulating Tumor Cell (CTC) Diagnostics: Technologies and Global Markets

出版日: | 発行: BCC Research | ページ情報: 英文 157 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
循環腫瘍細胞(CTC)診断:技術と世界市場
出版日: 2022年02月01日
発行: BCC Research
ページ情報: 英文 157 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の循環腫瘍細胞(CTC)診断の市場規模は、2021年に88億米ドルとなりました。

同市場は、2021年~2026年にかけて15.6%のCAGRで拡大し、2026年には152億米ドルになると予測されています。

当レポートでは、世界の循環腫瘍細胞(CTC)診断市場について調査し、市場の概要とともに、癌タイプ別、技術別、用途別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 イントロダクション

第2章 まとめとハイライト

第3章 市場と技術の背景

  • 最近の技術進歩
  • 侵襲力
  • 循環腫瘍細胞
  • 表現型の特徴
  • CTCクラスター
  • CTC検出
  • 癌幹細胞(CSC)
  • 循環腫瘍細胞-潜在的な用途
  • 増殖活性
  • 循環腫瘍細胞上の上皮マーカー遺伝子
  • 循環腫瘍細胞および幹細胞様表現型
  • CTCと初代腫瘍細胞:比較
  • 転移
  • 今後の方向性
  • 癌患者における転移性発達
  • 循環腫瘍細胞の遊走
  • 循環腫瘍細胞の検出
  • 手法
  • 検出の課題
  • 循環腫瘍DNAの臨床応用
  • 治療への反応の予測因子としての循環腫瘍細胞
  • CTCの測定-用途
  • 結論

第4章 CTC診断技術

  • 循環腫瘍細胞の発見
  • なぜCTCなのか?
  • 現在のCTCの検出および分離方法
  • 検出のための新技術
  • 癌の予後
  • 核酸ベースの方法
  • 臨床試験
  • 概要
  • 新しい新興技術

第5章 CTC診断市場に対するCOVID-19の影響

  • 概要
  • COVID-19と癌検診
  • COVID-19が企業の収益に与える影響

第6章 市場力学

第7章 市場内訳、癌タイプ別

  • 世界のCTC診断市場、癌タイプ別
  • 乳癌
  • 大腸癌
  • 前立腺癌

第8章 市場内訳、技術別

  • 世界のCTC診断市場、技術別
  • CTCの強化と検出
  • CTC直接検出
  • CTC分析

第9章 市場内訳、用途別

  • 世界のCTC診断市場、用途別
  • 臨床/リキッドバイオプシー
  • 研究

第10章 市場内訳、地域別

  • 世界のCTC診断市場、地域別
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第11章 企業プロファイル

  • BIO-TECHNE CORP.(ADVANCED CELL DIAGNOSTICS INC.)
  • BIOCEPT, INC.
  • BIOFLUIDICA
  • CREATV MICROTECH INC.
  • FLUXION BIOSCIENCES, INC.
  • GREINER BIO-ONE INTERNATIONAL GMBH
  • IKONISYS, INC.
  • IVDIAGNOSTICS, INC.
  • MENARINI SILICON BIOSYSTEMS(FORMERLY VERIDEX LLC)
  • MILTENYI BIOTEC
  • PRECISION MEDICINE GROUP LLC
  • QIAGEN N.V.
  • RARECELLS, INC.
  • SCREENCELL
  • STEMCELL TECHNOLOGIES INC.

第12章 付録:頭字語のリスト

図表

List of Tables

Table A : New Additions to the Updated Version of the Report

  • Summary Table : Global Market for Circulating Tumor Cells (CTC) Diagnostics, by Cancer Type, Through 2026
  • Table 1 : Categories of Stem Cells
  • Table 2 : Product Categories
  • Table 3 : Key Characteristics of CTCs
  • Table 4 : Types of CTCs
  • Table 5 : Circulating Tumor Cells Features
  • Table 6 : Metastatic Cascade
  • Table 7 : EPCAM-Based Assays
  • Table 8 : Comparison of Different Liquid Biopsy Technologies
  • Table 9 : Potential Applications of CTC-Based Diagnostics
  • Table 10 : Clinical Relevance of CTC
  • Table 11 : CTC Enrichment Methods
  • Table 12 : Techniques Used for CTC Enrichment
  • Table 13 : Techniques Used for CTC Analysis
  • Table 14 : Enumeration Techniques
  • Table 15 : Functional Assays
  • Table 16 : Circulating Tumor Cells Technologies
  • Table 17 : Micro-Count Features: A New Technology
  • Table 18 : Ranking of Global Vendors of CTC Diagnostics, 2020
  • Table 19 : Global Market for CTC Diagnostics, by Cancer Type, Through 2026
  • Table 20 : Global Market for CTC Diagnostics for Breast Cancer, by Region, Through 2026
  • Table 21 : Global Market for CTC Diagnostics for Colorectal Cancer, by Region, Through 2026
  • Table 22 : Global Market for CTC Diagnostics for Prostate Cancer, by Region, Through 2026
  • Table 23 : Global Market for CTC Diagnostics, by Technology, Through 2026
  • Table 24 : CTC Enrichment Methods
  • Table 25 : Global Market for CTC Enrichment and Detection, by Region, Through 2026
  • Table 26 : Global Market for CTC Direct Detection, by Region, Through 2026
  • Table 27 : Global Market for CTC Analysis, by Region, Through 2026
  • Table 28 : Global Market for CTC Diagnostics, by Application, Through 2026
  • Table 29 : Global Market for CTC Diagnostics in Clinical/Liquid Biopsy Applications, by Region, Through 2026
  • Table 30 : Global Market for CTC Diagnostics in Research Applications, by Region, Through 2026
  • Table 31 : Global Market for CTC Diagnostics, by Region, Through 2026
  • Table 32 : North American Market for CTC Diagnostics, by Cancer Type, Through 2026
  • Table 33 : North American Market for CTC Diagnostics, by Country, Through 2026
  • Table 34 : Estimated Number of New Cases and Age-Standardized Incidence Rates for Cancers in Canada, by Sex, 2020
  • Table 35 : European Market for CTC Diagnostics, by Cancer Type, Through 2026
  • Table 36 : European Market for CTC Diagnostics, by Country, Through 2026
  • Table 37 : Asia-Pacific Market for CTC Diagnostics, by Cancer Type, Through 2026
  • Table 38 : Asia-Pacific Market for CTC Diagnostics, by Country, Through 2026
  • Table 39 : Age-Standardized Cancer Incidence and Mortality Rates in China, by Gender, 2018
  • Table 40 : Rest of World Market for CTC Diagnostics, by Cancer Type, Through 2026
  • Table 41 : Bio-Techne Corp. (Advanced Cell Diagnostics Inc.): R&D Expenditures, 2018-2020
  • Table 42 : Bio-Techne Corp. (Advanced Cell Diagnostics Inc.): Products Offered
  • Table 43 : Bio-Techne Corp. (Advanced Cell Diagnostics Inc.): Recent Developments
  • Table 44 : Biocept, Inc.: R&D Expenditures, 2019 and 2020
  • Table 45 : Biocept, Inc.: Solutions/Services Offered
  • Table 46 : Biocept, Inc.: Recent Developments
  • Table 47 : BioFluidica: Solutions/Services Offered
  • Table 48 : BioFluidica: Recent Developments
  • Table 49 : Creatv MicroTech Inc.: Products Offered
  • Table 50 : Creatv MicroTech Inc: Recent Developments
  • Table 51 : Fluxion Biosciences, Inc.: Solutions/Services Offered
  • Table 52 : Fluxion Biosciences, Inc.: Recent Developments
  • Table 53 : Greiner Bio-One International GmbH: Products Offered
  • Table 54 : Ikonisys, Inc.: Products Offered
  • Table 55 : Ikonisys, Inc.: Recent Developments
  • Table 56 : IVDiagnostics, Inc.: Products/Services Offered
  • Table 57 : IVDiagnostics, Inc.: Recent Developments
  • Table 58 : Menarini Silicon Biosystems: Products Offered
  • Table 59 : Menarini Silicon Biosystems: Recent Developments
  • Table 60 : Miltenyi Biotec: Products Offered
  • Table 61 : Precision Medicine Group LLC: Products Offered
  • Table 62 : Precision Medicine Group LLC: Recent Developments
  • Table 63 : Qiagen: Products Offered
  • Table 64 : Qiagen: Recent Developments
  • Table 65 : Rarecells, Inc.: Products Offered
  • Table 66 : Rarecells, Inc.: Recent Developments
  • Table 67 : ScreenCell: Products Offered
  • Table 68 : ScreenCell: Recent Developments, 2021
  • Table 69 : STEMCELL Technologies Inc.: Products/Services Offered
  • Table 70 : STEMCELL Technologies Inc.: Recent Developments
  • Table 71 : Commonly Used Acronyms in the Market for CTC Diagnostics

List of Figures

  • Summary Figure : Global Market Shares of Circulating Tumor Cells (CTC) Diagnostics, by Cancer Type, 2020
  • Figure 1 : Global Market Shares of CTC Diagnostics, by Cancer Type, 2020
  • Figure 2 : Global Market for CTC Diagnostics for Breast Cancer, 2019-2026
  • Figure 3 : Global Market for CTC Diagnostics for Breast Cancer, by Region, 2019-2026
  • Figure 4 : Global Market for CTC Diagnostics for Colorectal Cancer, 2019-2026
  • Figure 5 : Global Market for CTC Diagnostics for Colorectal Cancer, by Region, 2019-2026
  • Figure 6 : Global Market for CTC Diagnostics for Prostate Cancer, 2019-2026
  • Figure 7 : Global Market for CTC Diagnostics for Prostate Cancer, by Region, 2019-2026
  • Figure 8 : Global Market Shares of CTC Diagnostics, by Technology, 2020
  • Figure 9 : Global Market for CTC Enrichment and Detection, 2019-2026
  • Figure 10 : Global Market for CTC Enrichment and Detection, by Region, 2019-2026
  • Figure 11 : Global Market for CTC Direct Detection, 2019-2026
  • Figure 12 : Global Market for CTC Direct Detection, by Region, 2019-2026
  • Figure 13 : Global Market for CTC Analysis, 2019-2026
  • Figure 14 : Global Market for CTC Analysis, by Region, 2019-2026
  • Figure 15 : Global Market Shares of CTC Diagnostics, by Application, 2020
  • Figure 16 : Global Market for CTC Diagnostics in Clinical/Liquid Biopsy Applications, 2019-2026
  • Figure 17 : Global Market for CTC Diagnostics in Clinical/Liquid Biopsy Applications, by Region, 2019-2026
  • Figure 18 : Global Market for CTC Diagnostics in Research Applications, 2019-2026
  • Figure 19 : Global Market for CTC Diagnostics in Research Applications, by Region, 2019-2026
  • Figure 20 : Global Market for CTC Diagnostics, by Region, 2019-2026
  • Figure 21 : Global Market Shares of CTC Diagnostics, by Region, 2020
  • Figure 22 : North American Market Shares of CTC Diagnostics, by Cancer Type, 2020
  • Figure 23 : North American Market Shares of CTC Diagnostics, by Country, 2020
  • Figure 24 : U.S. Market for CTC Diagnostics, 2019-2026
  • Figure 25 : Canadian Market for CTC Diagnostics, 2019-2026
  • Figure 26 : European Market Shares of CTC Diagnostics, by Cancer Type, 2020
  • Figure 27 : European Market Shares of CTC Diagnostics, by Country, 2020
  • Figure 28 : German Market for CTC Diagnostics, 2019-2026
  • Figure 29 : French Market for CTC Diagnostics, 2019-2026
  • Figure 30 : U.K. Market for CTC Diagnostics, 2019-2026
  • Figure 31 : Italian Market for CTC Diagnostics, 2019-2026
  • Figure 32 : Spanish Market for CTC Diagnostics, 2019-2026
  • Figure 33 : Rest of European Market for CTC Diagnostics, 2019-2026
  • Figure 34 : Asia-Pacific Market Shares of CTC Diagnostics, by Cancer Type, 2020
  • Figure 35 : Asia-Pacific Market Shares of CTC Diagnostics, by Country, 2020
  • Figure 36 : Chinese Market for CTC Diagnostics, 2019-2026
  • Figure 37 : Indian Market for CTC Diagnostics, 2019-2026
  • Figure 38 : Japanese Market for CTC Diagnostics, 2019-2026
  • Figure 39 : Australian Market for CTC Diagnostics, 2019-2026
  • Figure 40 : Rest of Asia-Pacific Market for CTC Diagnostics, 2019-2026
  • Figure 41 : Rest of World Market Shares of CTC Diagnostics, by Cancer Type, 2020
  • Figure 42 : Bio-Techne Corp. (Advanced Cell Diagnostics Inc.): Net Revenue, 2016-2020
  • Figure 43 : Bio-Techne Corp. (Advanced Cell Diagnostics Inc.): Revenue Share, by Business Segment, 2020
  • Figure 44 : Bio-Techne Corp. (Advanced Cell Diagnostics Inc.): Revenue Share, by Region, 2020
  • Figure 45 : Biocept, Inc.: Net Revenue, 2016-2020
  • Figure 46 : Greiner Bio-One International GmbH: Net Revenue, 2016-2020
  • Figure 47 : Greiner Bio-One International GmbH: Revenue Share, by Business Segment, 2020
  • Figure 48 : Greiner Bio-One International GmbH: Revenue Share, by Region, 2020
  • Figure 49 : Qiagen: Net Revenue, 2016-2020
  • Figure 50 : Qiagen: Revenue Share, by Business Segment, 2020
  • Figure 51 : Qiagen: Revenue Share, by Region, 2020
目次
Product Code: PHM153C

Highlights:

The global market for circulating tumor cells (CTC) diagnostics is estimated to increase from $8.8 billion in 2021 to $15.2 billion by 2026, at a compound annual growth rate (CAGR) of 15.6% during the forecast period of 2021-2026.

The global market for breast cancer diagnostics is estimated to increase from $3.6 billion in 2021 to $7.3 billion by 2026, at a CAGR of 15.3% during the forecast period of 2021-2026.

The global market for colorectal cancer diagnostics is estimated to increase from $2.9 billion in 2021 to $6.0 billion by 2026, at a CAGR of 16.0% during the forecast period of 2021-2026.

Report Scope:

The scope of this study involves clinical testing, prognostic and monitoring markets for CTCs in cancer. The report also includes the clinical research segment as well as currently approved CTC tests and their markets. The regulatory environment, current technologies, new technologies, cancer incidence, market projections and market share, along with the latest trends and new developments in this area, are included to support the clinical testing market.

Based on cancer type, the market for circulating tumor cells diagnostics is segmented into breast cancer, colorectal cancer and prostate cancer.

Based on technology, the market for circulating tumor cells diagnostics is segmented into CTC enrichment and detection, CTC direct detection and CTC analysis.

Based on application, the market for circulating tumor cells diagnostics is segmented into clinical/liquid biopsy and research.

The report discusses the qualitative and quantitative factors influencing market growth. Market drivers, restraints and opportunities are discussed in the report.

This report discusses some of the major drivers and restraints in the market for circulating tumor cells diagnostics, and it surveys the competitive landscape as well as the key players' strategies and performances. The discussion is focused on the major market players, trends in product launches, collaborations, and mergers and acquisitions. The report also includes company profiles of major vendors that include a company overview, key product offerings, financial statistics and recent developments. The report provides insights on market shares and upcoming regional demand for circulating tumor cells diagnostics.

Some of the major market players discussed in the report are Qiagen N.V., Biocept Inc., Greiner Bio One International GmbH, Precision Medicine Group LLC and Menarini Silicon Biosystems. For market estimates, data have been provided for the 2020 as the base year, with forecasts for 2021 through 2026. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.

Report Includes:

  • 24 data tables and 49 additional tables
  • An up-to-date review and analysis of the global markets for circulating tumor cell (CTC) diagnostics
  • Analyses of the global market trends, with data from 2019-2021, and projections of compound annual growth rates (CAGRs) through 2026
  • Highlights of the upcoming market opportunities in the CTC diagnostics industry, and areas of focus to forecast this market into various segments and sub-segments
  • Evaluation and forecast the global CTC diagnostics market size, forecasted growth trends, and corresponding market share analysis by cancer type, technology, application, and region
  • In-depth information concerning market drivers and challenges, latest technologies, breakthrough innovations, costs and benefits of CTC enrichment techniques, regulatory concerns, and clinical trials
  • Statistical information (facts and figures) on cancer incidence and prevalence, global cancer related deaths, and new cases of cancer by type in the United States
  • Review of recent industry trends, value chain analysis, competitive landscape, and COVID-19 implications within the marketplace
  • Descriptive company profiles of the leading global players, including Bio-Techne Corp., Biocept Inc., Greiner Bio-One International GmbH, Precision Medicine Group LLC, Menarini Silicon Biosystems, and Qiagen N.V.

Table of Contents

Chapter 1 Introduction

  • Study Background
  • Study Goals and Objectives
  • Reasons for Doing this Study
  • Scope of Report
  • What's New in this Update?
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

  • Cancer
  • Recent Advances in Technology
  • Invasive Power
  • Circulating Tumor Cells
  • Phenotypic Characteristics
  • CTC Clusters
  • CTC Detection
  • Cancer Stem Cells (CSCs)
  • Circulating Tumor Cells -- Potential Uses
  • Proliferative Activity
  • Epithelial Marker Genes on Circulating Tumor Cells
  • Circulating Tumor Cells and Stem Cell-Like Phenotype
  • CTCs and Primary Tumor Cells: A Comparison
  • Metastasis
  • Future Directions
  • Metastatic Development in Cancer Patients
  • Circulating Tumor Cell Migration
  • Circulating Tumor Cell Detection
  • Methods
  • CellSearch Method
  • Epic Sciences Method
  • Maintrac
  • ISET Test
  • Challenges for Detection
  • Clinical Application of Circulating Tumor DNA
  • Circulating Tumor Cells as Predictor of Response to Therapy
  • Measurement of CTCs -- Applications
  • Conclusion

Chapter 4 CTC Diagnostic Technologies

  • Finding Circulating Tumor Cells
  • Why CTCs?
  • Current CTC Detection and Isolation Methods
  • New Technologies for Detection
  • Cancer Prognosis
  • Nucleic Acid-Based Methods
  • Clinical Testing
  • Summary
  • New Emerging Technologies

Chapter 5 Impact of COVID-19 on the CTC Diagnostics Market

  • Overview
  • COVID-19 and Cancer Screening
  • Impact of COVID-19 on Company Revenues

Chapter 6 Market Dynamics

  • Market Drivers
  • Rising Incidence of Cancer Worldwide
  • Advantages Offered, by Noninvasivene Approach, by Circulating Tumor Cells
  • Advancements in NGS and Immunofluorescence Technologies
  • Growing Awareness About the Novel Diagnostic Methods for Cancers
  • Market Restraints
  • High Costs of CTC Diagnostics
  • Rarity of CTCs in Blood Samples and Lack of Skilled Professionals for CTC Diagnostics
  • Market Opportunities
  • Circulating Tumor Cells as a Therapeutic Target
  • Competitive Landscape

Chapter 7 Market Breakdown by Cancer Type

  • Global Market for CTC Diagnostics by Cancer Type
  • Breast Cancer
  • Colorectal Cancer
  • Prostate Cancer

Chapter 8 Market Breakdown by Technology

  • Global Market for CTC Diagnostics by Technology
  • CTC Enrichment and Detection
  • CTC Direct Detection
  • CTC Analysis

Chapter 9 Market Breakdown by Application

  • Global Market for CTC Diagnostics by Application
  • Clinical/Liquid Biopsy
  • Research

Chapter 10 Market Breakdown by Region

  • Global Market for CTC Diagnostics by Region
  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Chapter 11 Company Profiles

  • BIO-TECHNE CORP. (ADVANCED CELL DIAGNOSTICS INC.)
  • BIOCEPT, INC.
  • BIOFLUIDICA
  • CREATV MICROTECH INC.
  • FLUXION BIOSCIENCES, INC.
  • GREINER BIO-ONE INTERNATIONAL GMBH
  • IKONISYS, INC.
  • IVDIAGNOSTICS, INC.
  • MENARINI SILICON BIOSYSTEMS (FORMERLY VERIDEX LLC)
  • MILTENYI BIOTEC
  • PRECISION MEDICINE GROUP LLC
  • QIAGEN N.V.
  • RARECELLS, INC.
  • SCREENCELL
  • STEMCELL TECHNOLOGIES INC.

Chapter 12 Appendix: List of Acronyms